You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI
Search all articles
Vaccines
Submit to Vaccines

Vaccines, Volume 10, Issue 6

June 2022 - 152 articles

Cover Story: Patients from socially deprived and ethnic minority backgrounds associated with increased COVID-19 vaccine hesitancy are over-represented in the renal replacement therapy (RRT) population. A bespoke vaccination programme was designed with the involvement of a multidisciplinary team, using clinical teams as trusted messengers, patient engagement, local safety, and efficacy data to ensure equitable access to this life-saving intervention. The results of the programme showed that the total uptake for a first dose of COVID-19 vaccination was high at 96.7% and there were no statistically significant differences in patients from ethnic minority groups or socially deprived backgrounds. The vaccination uptake was higher compared to the reference regional adult clinically extremely vulnerable population. This work can inform other initiatives to address health inequalities in RRT patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (152)

  • Article
  • Open Access
3 Citations
3,729 Views
13 Pages
Download PDF

Pneumococcal Carriage in Infants Post-PCV10 Introduction in Pakistan: Results from Serial Cross-Sectional Surveys

  • Shahira Shahid,
  • Amala Khan,
  • Muhammad Imran Nisar,
  • Farah Khalid,
  • Muhammad Farrukh Qazi,
  • Sheraz Ahmed,
  • Furqan Kabir,
  • Aneeta Hotwani,
  • Sahrish Muneer and
  • Syed Asad Ali
  • + 3 authors
Vaccines2022, 10(6), 971;https://doi.org/10.3390/vaccines10060971

18 June 2022

The 10-valent pneumococcal vaccine was introduced in Pakistan’s Expanded Program on Immunization (EPI) in 2013 as a 3 + 0 schedule without catchup. We conducted three annual cross-sectional surveys from 2014–2016 to measure vaccine-type (...

Full Article
  • Article
  • Open Access
9 Citations
6,861 Views
14 Pages
Download PDF

Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (CovishieldTM) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021

  • Sharan Murali,
  • Manikandanesan Sakthivel,
  • Kamaraj Pattabi,
  • Vettrichelvan Venkatasamy,
  • Jeromie Wesley Vivian Thangaraj,
  • Anita Shete,
  • Alby John Varghese,
  • Jaganathan Arjun,
  • Chethrapilly Purushothaman Girish Kumar and
  • Pragya D Yadav
  • + 21 authors
Vaccines2022, 10(6), 970;https://doi.org/10.3390/vaccines10060970

17 June 2022

We estimated the effectiveness of two doses of the ChAdOx1 nCoV-19 (Covishield) vaccine against any COVID-19 infection among individuals ≥45 years in Chennai, Tamil Nadu, India. A community-based cohort study was conducted from May to September 20...

Full Article
  • Article
  • Open Access
19 Citations
4,286 Views
13 Pages
Download PDF

Opposing Role of Trust as a Modifier of COVID-19 Vaccine Uptake in an Indigenous Population

  • Ruben Juarez,
  • Krit Phankitnirundorn,
  • May Okihiro and
  • Alika K. Maunakea
Vaccines2022, 10(6), 968;https://doi.org/10.3390/vaccines10060968

17 June 2022

Native Hawaiians and other Pacific Islanders (NHPIs) were disproportionately impacted by COVID-19 and remain significantly under-vaccinated against SARS-CoV-2. To understand vaccine hesitancy, we surveyed 1124 adults residing in a region with one of...

Full Article
  • Article
  • Open Access
7 Citations
2,754 Views
17 Pages
Download PDF

Early IgE Production Is Linked with Extrafollicular B- and T-Cell Activation in Low-Dose Allergy Model

  • Dmitrii Borisovich Chudakov,
  • Olga Dmitrievna Kotsareva,
  • Maryia Vladimirovna Konovalova,
  • Daria Sergeevna Tsaregorodtseva,
  • Marina Alexandrovna Shevchenko,
  • Anton Andreevich Sergeev and
  • Gulnar Vaisovna Fattakhova
Vaccines2022, 10(6), 969;https://doi.org/10.3390/vaccines10060969

17 June 2022

Despite its paramount importance, the predominant association of early IgE production with harmless antigens, via germinal-center B- and T-cell subpopulations or extrafollicular activation, remains unresolved. The aim of this work was to clarify whet...

Full Article
  • Article
  • Open Access
16 Citations
2,794 Views
14 Pages
Download PDF

BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients

  • Michal Herman-Edelstein,
  • Naomi Ben-Dor,
  • Timna Agur,
  • Tali Guetta,
  • Annat Raiter,
  • Eshcar Meisel,
  • Weaam Alkeesh,
  • Yaacov Ori,
  • Benaya Rozen-Zvi and
  • Boris Zingerman
Vaccines2022, 10(6), 967;https://doi.org/10.3390/vaccines10060967

17 June 2022

Background: The emergence of new SARS-CoV-2 variants, which evade immunity, has raised the urgent need for multiple vaccine booster doses for vulnerable populations. In this study, we aimed to estimate the BNT162b2 booster effectiveness against the s...

Full Article
  • Article
  • Open Access
28 Citations
4,854 Views
16 Pages
Download PDF

Facilitators and Barriers to Take up a COVID-19 Vaccine Booster Dose among Community-Dwelling Older Adults in Hong Kong: A Population-Based Random Telephone Survey

  • Zixin Wang,
  • Yuan Fang,
  • Fuk-yuen Yu,
  • Paul Shing-fong Chan,
  • Siyu Chen and
  • Fenghua Sun
Vaccines2022, 10(6), 966;https://doi.org/10.3390/vaccines10060966

17 June 2022

A COVID-19 vaccine booster dose is effective and safe for older adults. This study investigated facilitators and barriers to take up a COVID-19 vaccine booster dose among older adults in Hong Kong. Participants were Chinese-speaking community-dwellin...

Full Article
  • Brief Report
  • Open Access
4 Citations
3,035 Views
6 Pages
Download PDF

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

  • Yohei Funakoshi,
  • Kimikazu Yakushijin,
  • Goh Ohji,
  • Wataru Hojo,
  • Hironori Sakai,
  • Marika Watanabe,
  • Akihito Kitao,
  • Yoshiharu Miyata,
  • Yasuyuki Saito and
  • Shinichiro Kawamoto
  • + 8 authors
Vaccines2022, 10(6), 965;https://doi.org/10.3390/vaccines10060965

17 June 2022

Anti-CD20 antibodies react with CD20 expressed not only on malignant B cells, but also on normal B cells. It has been reported that patients treated with anti-CD20 antibodies had an insufficient response to two-dose mRNA SARS-CoV-2 vaccination. To in...

Full Article
  • Case Report
  • Open Access
2 Citations
16,219 Views
6 Pages
Download PDF

Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy

  • Han Gyu Cha,
  • Dong Gyu Kim and
  • Joon Ho Choi
Vaccines2022, 10(6), 964;https://doi.org/10.3390/vaccines10060964

16 June 2022

Lymphadenopathy after coronavirus disease 2019 (COVID-19) vaccination is a common side effect that usually resolves within several days to weeks, and only observation is recommended. However, for prolonged lymphadenopathy, other possibilities, includ...

Full Article
  • Article
  • Open Access
11 Citations
5,284 Views
32 Pages
Download PDF

Natural History of Sudan ebolavirus to Support Medical Countermeasure Development

  • Caroline Carbonnelle,
  • Marie Moroso,
  • Delphine Pannetier,
  • Sabine Godard,
  • Stéphane Mély,
  • Damien Thomas,
  • Aurélie Duthey,
  • Ophélie Jourjon,
  • Orianne Lacroix and
  • Béatrice Labrosse
  • + 9 authors
Vaccines2022, 10(6), 963;https://doi.org/10.3390/vaccines10060963

16 June 2022

Sudan ebolavirus (SUDV) is one of four members of the Ebolavirus genus known to cause Ebola Virus Disease (EVD) in humans, which is characterized by hemorrhagic fever and a high case fatality rate. While licensed therapeutics and vaccines are availab...

Full Article
  • Article
  • Open Access
18 Citations
2,982 Views
15 Pages
Download PDF

Positive Attribute Framing Increases COVID-19 Booster Vaccine Intention for Unfamiliar Vaccines

  • Kirsten Barnes and
  • Ben Colagiuri
Vaccines2022, 10(6), 962;https://doi.org/10.3390/vaccines10060962

16 June 2022

Positive framing has been proposed as an intervention to increase COVID-19 vaccination intentions. However, available research has examined fictitious or unfamiliar treatments. This pre-registered study (aspredicted#78369) compared the effect of stan...

Full Article
Go to previous page

of 16

Go to next page

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X
Imprint
Download Flyer